Dx Dialogues: NASH

Featured Content

• 

  Article

  Diagnosis and Management of NASH

  Diagnosing NASH requires a liver biopsy, though less invasive methods are in development.

• 

  Article

  Expanding Treatment Options for NASH

  Treatment for NASH now includes the first FDA-approved pharmacotherapy.

• 

  Article

  Non-Alcoholic Steatohepatitis

  NASH affects 15 million people in the U.S. and significantly increases the risk of cirrhosis, hepatocellular carcin...

• 

  Article

  FDA Approves First Treatment for NASH

  For the first time, patients with non-alcoholic steatohepatitis with scarring have an approved therapy.